### 32459 Federal Register / Vol. 78, No. 104 / Thursday, May 30, 2013 / Notices

Aldrich Research Biochemicals, Inc., 1– 3 Strathmore Road, Natick, Massachusetts 01760–2447, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Drug Schedule

Cathinone (1235) .......................... I Methcathinone (1237) .................. I Aminorex (1585) ........................... I Alpha-ethyltryptamine (7249) ....... I Lysergic acid diethylamide (7315) I Tetrahydrocannabinols (7370) ..... I 4-Bromo-2,5-

dimethoxyamphetamine (7391). I

4-Bromo-2,5-

dimethoxyphenethylamine (7392). I

2,5-Dimethoxyamphetamine

(7396). I

3,4-Methylenedioxyamphetamine

(7400). I

N-Hydroxy-3,4-

methylenedioxyamphetamine (7402). I

3,4-Methylenedioxy-Nethylamphetamine (7404). I

3,4-

Methylenedioxymethamphetamine (MDMA) (7405). I

Psilocybin (7437) .......................... I5-Methoxy-N,Ndiisopropyltryptamine (7439). I

1-[1-(2-

Thienyl)cyclohexyl]piperidine (TCP) (7470). I

N-Benzylpiperazine (BZP) (7493) I Heroin (9200) ............................... I Normorphine (9313) ..................... I Amphetamine (1100) .................... II Methamphetamine (1105) ............ II Nabilone (7379) ............................ II 1-Phenylcyclohexylamine (7460) II Phencyclidine (7471) .................... II Cocaine (9041) ............................. II Codeine (9050) ............................. II Ecgonine (9180) ........................... II Levomethorphan (9210) ............... II Levorphanol (9220) ...................... II Meperidine (9230) ........................ II Metazocine (9240) ........................ II Methadone (9250) ........................ II Morphine (9300) ........................... II Thebaine (9333) ........................... II Levo-alphacetylmethadol (9648) .. II Remifentanil (9739) ...................... II Carfentanil (9743) ......................... II Fentanyl (9801) ............................ II

The company plans to manufacture reference standards.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Sigma Aldrich Research Biochemicals, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Sigma Aldrich Research Biochemicals, Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: May 22, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 2013–12832 Filed 5–29–13; 8:45 am]

**BILLING CODE 4410–09–P**

**DEPARTMENT OF JUSTICE**

**Drug Enforcement Administration**

**Manufacturer of Controlled Substances; Notice of Registration;**  **Mallinckrodt, LLC.**

By Notice dated February 8, 2013, and published in the Federal Register on February 21, 2013, 78 FR 12102, Mallinckrodt, LLC., 3600 North Second Street, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Drug Schedule

Tetrahydrocannabinols (7370) ..... I Codeine-N-oxide (9053) ............... I Dihydromorphine (9145) ............... I Difenoxin (9168) ........................... I Morphine-N-oxide (9307) ............. I Normorphine (9313) ..................... I Norlevorphanol (9634) .................. I Amphetamine (1100) .................... II Methamphetamine (1105) ............ II Methylphenidate (1724) ................ II Nabilone (7379) ............................ II 4-Anilino-N-phenethyl-4-piperidine

(8333). II

Codeine (9050) ............................. II Dihydrocodeine (9120) ................. II Oxycodone (9143) ........................ II Hydromorphone (9150) ................ II Diphenoxylate (9170) ................... II Ecgonine (9180) ........................... II Hydrocodone (9193) ..................... II Levorphanol (9220) ...................... II Meperidine (9230) ........................ II Methadone (9250) ........................ II Methadone intermediate (9254) ... II Dextropropoxyphene, bulk (non—

dosage forms) (9273). II

Morphine (9300) ........................... II Drug Schedule

Oripavine (9330) ........................... II Thebaine (9333) ........................... II Opium tincture (9630) .................. II Opium, powdered (9639) ............. II Oxymorphone (9652) ................... II Noroxymorphone (9668) .............. II Alfentanil (9737) ........................... II Remifentanil (9739) ...................... II Sufentanil (9740) .......................... II Fentanyl (9801) ............................ II

The firm plans to manufacture the listed controlled substances for internal use and for sale to other companies.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Mallinckrodt, LLC., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Mallinckrodt, LLC., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: May 22, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 2013–12831 Filed 5–29–13; 8:45 am]

**BILLING CODE 4410–09–P**

**DEPARTMENT OF LABOR**

**Office of the Secretary**

**Agency Information Collection Activities; Submission for OMB**  **Review; Comment Request; Reporting and Performance Standards for**  **Workforce Investment Act Indian and Native American Programs** 

**ACTION :**  Notice.

**SUMMARY :**  On May 31, 2013, the Department of Labor (DOL) will submit the Employment and Training (ETA) sponsored information collection request (ICR) revision titled, ‘‘Reporting and Performance Standards for Workforce Investment Act Indian and Native American Programs,’’ to the Office of Management and Budget


### 32460 Federal Register / Vol. 78, No. 104 / Thursday, May 30, 2013 / Notices

(OMB) for review and approval for use in accordance with the Paperwork Reduction Act (PRA) of 1995 (44 U.S.C. 3501 et seq.).

**DATES :**  Submit comments on or before July 1, 2013.

**ADDRESSES :**  A copy of this ICR with applicable supporting documentation; including a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained free of charge from the RegInfo.gov Web site at http:// www.reginfo.gov/public/do/ PRAViewICR?ref

_nbr=201212-1205-006 (this link will only become active on June 1, 2013) or by contacting Michel Smyth by telephone at 202–693–4129 (this is not a toll-free number) or sending an email to DOL

_PRA

_PUBLIC@dol.gov. Submit comments about this request to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for DOL–ETA, Office of Management and Budget, Room 10235, 725 17th Street, NW., Washington, DC 20503, Fax: 202–395–6881 (this is not a toll-free number), email: OIRA

_ submission@omb.eop.gov.

**FOR FURTHER INFORMATION CONTACT :**  Contact Michel Smyth by telephone at 202–693–4129 (this is not a toll-free number) or by email at DOL

_PRA

_PUBLIC@dol.gov. Authority: 44 U.S.C. 3507(a)(1)(D).

**SUPPLEMENTARY INFORMATION :**  This ICR covers the recordkeeping and reporting system for the Indian and Native Americans funded grants and has three constituent information collections: (1) A quarterly Comprehensive Services Program report (Form ETA–9084), (2) a Standardized Participant Information Record, and (3) a quarterly Supplemental Youth Services Program Report (Form ETA–9085). These three information collections are the basis of the performance standards system for Workforce Investment Act section 166 grantees.

The ETA is revising this ICR in the following manner. Form ETA 9084 will now capture the number of eligible veterans and spouses served (with the addition of two data fields). The DOL notes that Form ETA–9085 has already been recording this information and will not be changed. In addition, Form ETA– 9085 information will now be collected on the number of eligible youth between the ages of 14–21 years, rather than ages 14–24, which was allowed under the American Reinvestment and Recovery Act of 2009 (ARRA). Form ETA–9085 adds a credential attainment measure. Finally, Form-ETA 9085 data will revert to being collected quarterly, rather than monthly, as was the case prior to ARRA requirements. For additional substantive information about this ICR, see the related notice published in the Federal Register on March 28, 2013 (78 FR 19018).

This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless it is approved by the OMB under the PRA and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of law, no person shall generally be subject to penalty for failing to comply with a collection of information that does not display a valid Control Number. See 5 CFR 1320.5(a) and 1320.6. The DOL obtains OMB approval for this information collection under Control Number 1205–0422. The current approval is scheduled to expire on May 31, 2013; however, it should be noted that existing information collection requirements submitted to the OMB receive a month-to-month extension while they undergo review. New information collection requirements will only take effect upon OMB approval.

Interested parties are encouraged to send comments to the OMB, Office of Information and Regulatory Affairs at the address shown in the ADDRESSES section by July 1, 2013. In order to help ensure appropriate consideration, comments should mention OMB Control Number 1205–0422. The OMB is particularly interested in comments that:

• Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

• Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

• Enhance the quality, utility, and clarity of the information to be collected; and

• Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of
responses.

Agency: DOL-Employment and Training Administration. Title of Collection: Program Reporting and Performance Standards System for Indian and Native American Programs.

OMB Control Number: 1205–0422. Affected Public: Individuals or Households; State, Local, and TribalGovernments, and Private Sector—notfor-profit institutions.

Total Estimated Number of Respondents: 13,771.

Total Estimated Number of Responses: 28,110.

Total Estimated Annual Burden Hours: 53,611.

Total Estimated Annual Other Costs Burden: $0.

Dated: May 22, 2013. Michel Smyth, Departmental Clearance Officer.
[FR Doc. 2013–12756 Filed 5–29–13; 8:45 am]

**BILLING CODE 4510–FN–P**

**DEPARTMENT OF LABOR**

**Employment and Training Administration** 

**Comment Request for Information Collection for ETA Form 232, Domestic**  **Agricultural In-Season Wage Report and ETA Form 232–A, Wage Survey**  **Interview Record, Extension with Revisions** 

**AGENCY :**  Employment and Training Administration (ETA), Labor.

**ACTION :**  Notice.

**SUMMARY :**  The Department of Labor (Department), as part of its continuing effort to reduce paperwork and respondent burden, conducts a preclearance consultation program to provide the public and Federal agencies with an opportunity to comment on proposed and/or continuing collections of information in accordance with the Paperwork Reduction Act of 1995 [44 U.S.C. 3506(c)(2)(A)]. This program helps ensure that requested data can be provided in the desired format, reporting burden (time and financial resources) is minimized, collection instruments are clearly understood, and the impact of collection requirements on respondents can be properly assessed.

Currently, ETA is soliciting comments concerning the collection of data about ETA Form 232, Domestic Agricultural In-Season Wage Report and ETA Form 232–A, Wage Survey Interview Record, OMB Control No. 1205–0017, both of which expire July 31, 2013. These forms are used by the State Workforce Agencies to collect wage information from agricultural employers.

**DATES :**  Written comments must be submitted to the office listed in the